Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges
Cancer is one of the major leading causes of mortality in the world. The implication of nanotherapeutics in cancer has garnered splendid attention owing to their capability to efficiently address various difficulties associated with conventional drug delivery systems such as non-specific biodistribu...
Main Authors: | Sarah I. Bukhari, Syed Sarim Imam, Mohammad Zaki Ahmad, Parameswara Rao Vuddanda, Sultan Alshehri, Wael A. Mahdi, Javed Ahmad |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/6/840 |
Similar Items
-
Computational Approaches in Theranostics: Mining and Predicting Cancer Data
by: Tânia F. G. G. Cova, et al.
Published: (2019-03-01) -
Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges
by: Sultan Alshehri, et al.
Published: (2020-12-01) -
Cyanine conjugates in cancer theranostics
by: Yang Li, et al.
Published: (2021-03-01) -
Hybrid Quantum Dot as Promising Tools for Theranostic Application in Cancer
by: Javed Ahmad, et al.
Published: (2023-02-01) -
Metastatic Breast Cancer: Review of Emerging Nanotherapeutics
by: Ranga Dissanayake, et al.
Published: (2023-05-01)